← Browse by Condition
Medical Condition

her2 positive low expression urinary and digestive tract tumors

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06031584 Phase 1, Phase 2
Recruiting

A Study of BL-M07D1 in Patients With a Variety of Solid Tumors Including Locally Advanced or Metastatic HER2-positive/Low-expressing Urinary and Gastrointestinal Tumors

Enrollment
42 pts
Location
China
Sponsor
Sichuan Baili Pharmaceutical C...
View Trial →